16799-04-5

Basic information

• Product Name: 1-(2-Bromoethyl)-3-nitrobenzene
• Synonyms: 1-(2-Bromoethyl)-3-nitrobenzene;3-Nitrophenethyl bromide;Benzene, 1-(2-broMoethyl)-3-nitro-;3-Nitrophenethyl broMide 97%
• CAS NO: 16799-04-5
• Molecular Formula: C₈H₈BrNO₂
• Molecular Weight: 230.06
• Mol File: 16799-04-5.mol
• Article Data: 2

Chemical Properties

• Melting Point: 30-34 °C
• Boiling Point: 136-138 °C/0.5 mmHg
• Appearance: /
• Density: 1.562±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1-(2-Bromoethyl)-3-nitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-Bromoethyl)-3-nitrobenzene(16799-04-5)
• EPA Substance Registry System: 1-(2-Bromoethyl)-3-nitrobenzene(16799-04-5)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36-43
• Safety Statements: 26-36/37
• WGK Germany: 3
• Hazardous Substances Data: 16799-04-5(Hazardous Substances Data)

Usage

General Description

1-(2-Bromoethyl)-3-nitrobenzene is a chemical compound with the molecular formula C8H8BrNO2. It is a nitrobenzene derivative that contains a bromoethyl group attached to the benzene ring. 1-(2-Bromoethyl)-3-nitrobenzene is commonly used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and dyes. It is also utilized in organic synthesis as a building block for the preparation of more complex compounds. 1-(2-Bromoethyl)-3-nitrobenzene is known for its diverse reactivity and can undergo various chemical reactions such as nucleophilic substitution and reduction, making it a versatile molecule in organic chemistry. Additionally, it is important to handle this compound with caution as it may pose health and safety hazards due to its toxic and potentially harmful nature.

Upstream product

• 558-13-4 carbon tetrabromide 
• 52022-77-2 2-(3-nitrophenyl)ethanol 
• 1877-73-2 3-nitro-benzeneacetic acid 

Downstream Products

• 180079-58-7 N-(1-(3-nitrophenyl)ethyl)carbamic acid t-butyl ester 
• 1257078-19-5 4-(2-chloroimidazo[1,2-a]pyridin-3-yl)-N-(3-(2-(dimethylamino)ethyl)phenyl)pyrimidin-2-amine 
• 883977-08-0 3-(2-dimethylaminoethyl)phenylamine 
• 1426260-51-6 6-methoxy-2-(3-nitrophenethyl)-1,2,3,4-tetrahydroisoquinolin-7-ol 
• 1369303-80-9 1-[2-(3-nitrophenyl)ethyl]-4-phenylpiperazine 
• 1018265-20-7 3-[2-(4-phenylpiperazin-1-yl)ethyl]phenylamine 

Relevant articles and documents

PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS MODULATORS OF MULTIDRUG RESISTANCE

A compound which is a pyrrolopyrimidine of formula (I) wherein: R1 is selected from R9 and halogen; R2 is NR6R7; R3 is selected from H, C1-C6 alkyl which is unsubstituted or substituted and -(CH2) nAr; R4 is selected from H, C1-C6 alkyl and -(CH2)? Ar; or R3 and R4 form, together with the N and C atoms to which they are attached, a fused five-, six-, seven- or eight-membered N-containing saturated ring which is unsubstituted or substituted; R5 is selected from CN, C02R9,C(O)NR10R11, -(CH2)nOH, -(CH2)nR10Rn, -C=CH, -C(S)NR10R11, -C(NH2)=NOR9, -C(R9)=NOR9, -C(NH2)NH, -C(O)R9 and an unsaturated 5- or 6-membered heterocyclic group which contains 1, 2 or 3 heteroatoms selected from N, O and S and which is unsubstituted or substituted; R6 and R7, which are the same or different, are selected from C1-C6 alkyl which is unsubstituted or substituted, -(CH2)nX and -(CH2)nAr; or R6 and R7 form, together with the nitrogen atom to which they are attached, a saturated five-, six-, seven- or eight-membered heterocyclic group which contains one nitrogen atom and 0 or from 1 to 3 additional heteroatoms selected from N, O and S, which is unsubstituted or substituted and which optionally contains one or two bridgehead atoms; R10and R11,which are the same or different, are selected from H, C1-C6 alkyl which is unsubstituted or substituted, -(CH2)nC3-C10 cycloalkyl and -(CH2)nAr; or R10 and R11 form, together with the nitrogen atom to which they are attached, a saturated five or six membered heterocyclic group which contains a nitrogen atom and 0 or from to 3 additional heteroatoms selected from O, S and N, which is unsubstituted or substituted and which is optionally fused to a benzene ring which is unsubstituted or substituted; n is the same or different when more than one is present within a given substituent group and is 0 or an integer of from 1 to 6; X is selected from -CN, -C02R9 and -NR10R11; R9 is the same or different when more than one is present within a given substituent group and is selected from -H, -QAr, -(CH2) nAr, C1-C6 alkyl which is unsubstituted or substituted and -(CH2) nC3-C10cycloalkyl, wherein the cycloalkyl moiety is optionally fused to a benzene ring which is unsubstituted or substituted; Q is C2-C6 alkenylene or alkynylene; and Ar is an unsaturated C6-C10 membered carbocyclic group or an unsaturated 5-11 membered heterocyclic group, which groups are unsubstituted or substituted; or a pharmaceutically acceptable salt thereof. These compounds have activity as inhibitors of MRP (multidrug resistant protein) and may thus be used to modulate multidrug resistance, for instance in potentiating the cytotoxicity of a chemotherapeutic agent.